Back
Liquidia Vs. Arcturus Therapeutics Holdings Industry Stock Comparison
Sell
42
LQDA
Liquidia
Last Price:
9.96
Seasonality Move:
33.94%
Sell
28
ARCT
Arcturus Therapeutics Holdings
Last Price:
16.16
Seasonality Move:
4.49%
Sell
42
Liquidia (LQDA)
is a Sell
Is Liquidia a Buy, Sell or Hold?
- The current Liquidia [LQDA] share price is $10.03. The Score for LQDA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LQDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?
- The current Arcturus Therapeutics Holdings [ARCT] share price is $18.34. The Score for ARCT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings's stock price today?
-
The Arcturus Therapeutics Holdings share price today is $18.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.
LQDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 36.34 | Sell |
| Chaikin Money Flow: | -1087910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.57 - 11.25) | Sell |
| Bollinger Bands (100): | (9.83 - 12.05) | Sell |
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 41.14 | Sell |
| Chaikin Money Flow: | -378483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.38 - 20.62) | Sell |
| Bollinger Bands (100): | (19.22 - 23.26) | Sell |
LQDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.58 | Sell |
| 20-day SMA: | 10.83 | Sell |
| 50-day SMA: | 10.46 | Sell |
| 200-day SMA: | 12.4 | Sell |
| 8-day EMA: | 10.52 | Sell |
| 20-day EMA: | 10.69 | Sell |
| 50-day EMA: | 10.73 | Sell |
| 200-day EMA: | 11.12 | Sell |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.06 | Sell |
| 20-day SMA: | 19.14 | Sell |
| 50-day SMA: | 20.56 | Sell |
| 200-day SMA: | 27.21 | Sell |
| 8-day EMA: | 19.02 | Sell |
| 20-day EMA: | 19.39 | Sell |
| 50-day EMA: | 20.4 | Sell |
| 200-day EMA: | 24.43 | Sell |
Liquidia Earnings Growth & LQDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.39 per share.
Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.71 per share.
Liquidia Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcturus Therapeutics Holdings Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||